Author

D. Heid

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Ahadova· 1 shared A. B. Riemer· 1 shared A. Ballhausen· 1 shared A. Benner· 1 shared A. Heit-Mondrzyk· 1 shared B. Nijmeijer-Winter· 1 shared C. B. Vagbo· 1 shared C. Baldus· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ahadova

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Unbiased functional genetic screens reveal essential RNA modifications in human cancer and drug resistance

C. Pauli, M. Kienhoefer, M. Blank, O. Begik, C. Rohde, D. Heid, F. Xu, S. M. N. Zimmermann, K. Weidenauer, S. Delaunay, N. Krall, K. Trunk, D. Zhao, F. Zhou, A. Heit-Mondrzyk, , M. Frye

The paper identifies essential RNA modifications in cancer using CRISPR screens and finds that mitochondrial metabolic plasticity influences drug resistance through specific RNA modifications.

bioRxiv · Jul 13, 2024 · PreprintCell Biology

The shared neoantigen landscape of MSI cancers reflects immunoediting during tumor evolution

A. Ballhausen, M. J. Przybilla, M. Jendrusch, S. Haupt, E. Pfaffendorf, M. Draxlbauer, F. Seidler, S. Krausert, A. Ahadova, M. S. Kalteis, D. Heid, J. Gebert, M. Bonsack, S. Schott, H. Bläker, , M. Kloor

The study identifies shared immunogenic neoantigens in MSI cancers and finds a negative correlation between indel mutation frequency and neoantigen immunogenicity, suggesting immunoediting during tumor evolution.

bioRxiv · Jul 16, 2019Cancer Biology

Nuclear pores as versatile reference standards for quantitative superresolution microscopy

J. V. Thevathasan, M. Kahnwald, K. Cieslinski, P. Hoess, S. K. Peneti, M. Reitberger, D. Heid, K. C. Kasuba, S. J. Hoerner, Y. Li, Y.-L. Wu, M. Mund, U. Matti, P. M. Pereira, R. Henriques, , J. Ries

The paper uses genome-edited cell lines with labeled nuclear pore complexes to serve as reference standards for quantitative superresolution microscopy.

bioRxiv · Mar 20, 2019Biophysics